ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Materia Medica Holding clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 43 studies whose lead sponsor is Materia Medica Holding. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Materia Medica with Ahn-Gook Pharmaceuticals and GlaxoSmithKline →

Pipeline: 4 programs

Each counted once: 4 with a study Materia Medica Holding leads registered in the last two years.

  • Phase 1
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Materia Medica Holding’s own registered studies; Materia Medica Holding’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Materia Medica Holding’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Materia Medica Holding’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 43 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now49%
  • Under way, not recruiting12%
  • Completed3786%
  • Stopped early12%

Phase

  • Phase 325
  • Phase 414
  • Phase 12

Where

  • Russian Federation33
  • Russia8
  • Kazakhstan2
  • Ukraine2
  • Uzbekistan2
  • Belarus1

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 516
  8. 17
  9. 18
  10. 19
  11. 20
  12. 21
  13. 22
  14. 23
  15. 24
  16. 25
  17. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Materia Medica Holding.

  • Materia Medica Holding
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    43 studies

Studies

Recruiting first, then most recently updated. Showing 43 of 43.